What would help or hinder patient participation in mitochondrial disease clinical trials? Patient-centric perspective offers key insights into upcoming treatment studies

As clinical trials gear up with the aim of attaining the first FDA-approved treatments for mitochondrial disease, a new study

Chemical compound produces beneficial inflammation, remyelination that could help treat multiple sclerosis: Study shows that ‘good inflammation’ promotes axon myelination

Drugs available to treat multiple sclerosis, a leading cause of neurological disability affecting roughly 2.3 million people worldwide, alter the